Publications (selected)
Ionic mitigation of CD4+ T cell metabolic fitness, Th1 central nervous system autoimmunity and Th2 asthmatic airway inflammation by therapeutic zinc.
Krone A., Fu Y., Schreiber S. et al., 2022,
Sci. Rep.
Lipotoxicity as a Barrier for T Cell-Based Therapies.
Böttcher-Loschinski R et al., 2022, Biomolecules.
(Collaboration with Dimitrios Mougiakakos' group)
Institute of Molecular and
Clinical Immunology
Medical Faculty
Otto-von-Guericke University
Magdeburg
Leipziger Str. 44, Building 26
39120 Magdeburg
GERMANY
Nitric oxide controls proliferation of Leishmania major by inhibiting the recruitment of permissive host cells.
Formaglio P., Allabdullah M. et al., 2021, Immunity
(Collaboration with Andreas Müllers' group)
Metabolic Interdepedancy of Th2-mediated type 2
immunity and the Tumor Microenviroment.
Schreiber S. et al., 2021, Frontiers in Immunology
STIM1-mediated calcium influx controls antifungal immunity by regulating the metabolic function of non-pathogenic Th17 cells.
Kahlfuss S. et al., 2020, EMBO Molecular Medicine
CRAC channels and CalciumInflux in T Cell-Mediated Immunity.
Vaeth M., Kahlfuss S., Feske S., 2020, Trends in Immunology
Calcium signaling controls pathogenic Th17 cell-mediated inflammation by regulating mitochondrial function.
Kaufmann U., Kahlfuss S. et al., 2019, Cell Metabolism
ORAI1 mutations abolishing store-operated Ca2+ entry cause anhidrotic ectodermal dysplasia with immunodeficiency.
Lian J., Cuk M., Kahlfuss S. et al., 2018,
The Journal of Allergy and Clinical Immunology
